Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity
Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis
Selecta Biosciences Announces Merger with Cartesian Therapeutics
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates
Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics
Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call Transcript
Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update
4 Hot Penny Stocks To Watch With News This Week
Selecta Biosciences, Inc. (SELB) Q4 2022 Earnings Call Transcript
Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week
The 7 Best Biotech Stocks to Buy for February 2023
Selecta: Despite Challenges, Dissolve Topline Data Could Move The Stock
Selecta Biosciences, Inc. (SELB) Q3 2022 Earnings Call Transcript
What The Stock Market Did Today & Top Penny Stocks To Watch Now
Selecta Biosciences to Participate in Upcoming Investor Conferences
Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
Selecta Biosciences, Inc's (SELB) CEO Carsten Brunn on Q2 2022 Results - Earnings Call Transcript
Selecta Biosciences to Participate in Upcoming Investor Conferences
Selecta Biosciences, Inc. (SELB) Upgraded to Strong Buy: Here's What You Should Know
SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock
7 Cheap Biotech Stocks to Buy Now
Selecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference
Selecta Biosciences (SELB) CEO Carsten Brunn on Q1 2022 Results - Earnings Call Transcript
Selecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update
Selecta Biosciences (SELB) CEO Carsten Brunn on Q4 2021 Results - Earnings Call Transcript
Selecta Biosciences, Inc. (SELB) Reports Q4 Loss, Tops Revenue Estimates
Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update
Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
4 Penny Stocks Analysts Say To Buy Now & Targets Up To 117%
Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Right Now
10 Penny Stocks To Buy In December According To Insiders
Selecta Biosciences (SELB) Stock: Why The Price Fell Today
Selecta (SELB) Down on FDA's Clinical Hold on Phase I/II Study
Selecta Biosciences, Inc.'s (SELB) CEO Carsten Brunn on Q3 2021 Results - Earnings Call Transcript
Selecta Biosciences, Inc. (SELB) Reports Q3 Loss, Tops Revenue Estimates
Selecta Biosciences Posts Encouraging Data For ImmTOR Platform
Selecta Biosciences, Ginkgo Bioworks Join Forces To Develop Rare Disease Treatments
Selecta Biosciences to Present New Data for the ImmTOR™ platform at the ESGCT 28th Annual Congress
5 Top Penny Stocks Analysts Say To Buy Now With 123%-733% Targets
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
Selecta Biosciences to Participate in Cantor Virtual Global Healthcare Conference
Selecta Biosciences Announces Appointment of Kevin Tan as Chief Financial Officer
Selecta Biosciences to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q2 2021 Results - Earnings Call Transcript
Selecta Biosciences: Q2 Earnings Insights
New Strong Sell Stocks for July 14th
Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
Selecta Biosciences Has Multiple Shots On Goal